LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

XTL Biopharmaceuticals Ltd.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERXTLB
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / XTLB COVERAGE

What’s moving XTL Biopharmaceuticals Ltd. now

Current reporting with the operating signal separated from the noise.

01
XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Announces ADS Ratio Change

XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Announces ADS Ratio Change

The story matters when it changes XTL Biopharmaceuticals Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.

Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.

The development tests whether XTL Biopharmaceuticals Ltd. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
03
XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd.

The story matters when it changes XTL Biopharmaceuticals Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
XTL Biopharmaceuticals Ltd.: XTL Update on Recent Developments

XTL Biopharmaceuticals Ltd.: XTL Update on Recent Developments

The story matters when it changes XTL Biopharmaceuticals Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest XTLB filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

6-KOfficial SEC filingFiled 2026-07-21 · Period 2026-07-21SEC ↗20-FOfficial SEC filingFiled 2026-06-30 · Period 2025-12-31SEC ↗6-KOfficial SEC filingFiled 2026-06-30 · Period 2026-06-30SEC ↗6-KOfficial SEC filingFiled 2026-06-29 · Period 2026-06-29SEC ↗6-KOfficial SEC filingFiled 2026-06-23 · Period 2026-06-22SEC ↗6-KOfficial SEC filingFiled 2026-05-22 · Period 2026-05-22SEC ↗6-KOfficial SEC filingFiled 2026-05-15 · Period 2026-05-15SEC ↗6-KOfficial SEC filingFiled 2026-05-07 · Period 2026-05-07SEC ↗
EARNINGS / QUARTERLY TRACKER

XTL Biopharmaceuticals Ltd., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.